This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunocore Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jakub Jaworski: Innovator in Binding Molecules
Introduction
Jakub Jaworski is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that have the potential to revolutionize treatments for malignant diseases.
Latest Patents
Jakub holds a patent for his invention titled "Binding molecules." This innovative patent relates to binding molecules that comprise T cell receptor (TCR) variable domains, which can bind to a PIWIL1 peptide-HLA complex. The invention also encompasses the use of such molecules for the treatment of malignant diseases. He has 1 patent to his name.
Career Highlights
Jakub Jaworski is currently employed at Immunocore Limited, a company that focuses on developing innovative therapies for cancer and other diseases. His work at Immunocore has positioned him as a key player in the biotechnology sector.
Collaborations
Jakub collaborates with talented individuals such as Nicole Mai and Arnaud Techine, contributing to a dynamic and innovative work environment.
Conclusion
Jakub Jaworski's contributions to the field of binding molecules highlight his role as an important inventor in biotechnology. His work has the potential to impact the treatment of malignant diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile